JP2025500443A - 多重ベクターリコンビナーゼ媒介カセット交換 - Google Patents

多重ベクターリコンビナーゼ媒介カセット交換 Download PDF

Info

Publication number
JP2025500443A
JP2025500443A JP2024538052A JP2024538052A JP2025500443A JP 2025500443 A JP2025500443 A JP 2025500443A JP 2024538052 A JP2024538052 A JP 2024538052A JP 2024538052 A JP2024538052 A JP 2024538052A JP 2025500443 A JP2025500443 A JP 2025500443A
Authority
JP
Japan
Prior art keywords
host cell
nucleotides
sequence
vector
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024538052A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023122246A5 (https=
JP2025500443A5 (https=
Inventor
チー キン ドミンゴス ン，
エイミー シェン，
ギャビン クリスチャン バーナード，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of JP2025500443A publication Critical patent/JP2025500443A/ja
Publication of JPWO2023122246A5 publication Critical patent/JPWO2023122246A5/ja
Publication of JP2025500443A5 publication Critical patent/JP2025500443A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/40—Systems of functionally co-operating vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2024538052A 2021-12-22 2022-12-22 多重ベクターリコンビナーゼ媒介カセット交換 Pending JP2025500443A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163292869P 2021-12-22 2021-12-22
US63/292,869 2021-12-22
PCT/US2022/053761 WO2023122246A1 (en) 2021-12-22 2022-12-22 Multi-vector recombinase mediated cassette exchange

Publications (3)

Publication Number Publication Date
JP2025500443A true JP2025500443A (ja) 2025-01-09
JPWO2023122246A5 JPWO2023122246A5 (https=) 2025-12-25
JP2025500443A5 JP2025500443A5 (https=) 2025-12-25

Family

ID=85202223

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024538052A Pending JP2025500443A (ja) 2021-12-22 2022-12-22 多重ベクターリコンビナーゼ媒介カセット交換

Country Status (8)

Country Link
US (1) US20240409615A1 (https=)
EP (1) EP4453227A1 (https=)
JP (1) JP2025500443A (https=)
KR (1) KR20240117146A (https=)
CN (1) CN119731330A (https=)
CA (1) CA3239981A1 (https=)
TW (1) TW202342755A (https=)
WO (1) WO2023122246A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096222C (en) 1990-11-13 1998-12-29 Stephen D. Lupton Bifunctional selectable fusion genes
WO1994028143A1 (en) 1993-05-21 1994-12-08 Targeted Genetics Corporation Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
WO2004009792A2 (en) 2002-07-24 2004-01-29 Vanderbilt University Transposon-based vectors and methods of nucleic acid integration
BR112015031639A2 (pt) * 2013-06-19 2019-09-03 Sigma Aldrich Co Llc integração alvo
EA201892137A1 (ru) * 2016-04-20 2019-03-29 Регенерон Фармасьютикалз, Инк. Композиции и способы получения антител, основанные на применении локусов, обеспечивающих повышенную экспрессию
US11512144B2 (en) * 2016-04-20 2022-11-29 Regeneran Pharmaceuticals, Inc. Compositions and methods for making antibodies based on use of an expression-enhancing loci
IL275462B2 (en) * 2017-12-22 2026-01-01 Genentech Inc Targeted integration of nucleic acids

Also Published As

Publication number Publication date
US20240409615A1 (en) 2024-12-12
TW202342755A (zh) 2023-11-01
EP4453227A1 (en) 2024-10-30
CA3239981A1 (en) 2023-06-29
KR20240117146A (ko) 2024-07-31
CN119731330A (zh) 2025-03-28
WO2023122246A1 (en) 2023-06-29

Similar Documents

Publication Publication Date Title
US11634836B2 (en) Randomized configuration targeted integration of nucleic acids
US20220170049A1 (en) Method for the generation of a protein expressing cell by targeted integration using cre mrna
CN114008212B (zh) 通过以限定的组织形式靶向整合多个表达盒来产生三价抗体表达细胞的方法
US20220169731A1 (en) Method for the generation of a multivalent, bispecific antibody expressing cell by targeted integration of multiple expression cassettes in a defined organization
JP7572977B2 (ja) 所定の構成の複数の発現カセットの標的化組込みによって多価の多重特異性抗体発現細胞を作製するための方法
CN114008081A (zh) 通过以限定的组织形式靶向整合多个表达盒来产生二价双特异性抗体表达细胞的方法
US20240409615A1 (en) Multi-vector recombinase mediated cassette exchange
HK40109435A (zh) 通过使用cre mrna进行的靶向整合来产生蛋白质表达细胞的方法
HK40060851B (zh) 通过使用cre mrna进行的靶向整合来产生蛋白质表达细胞的方法
HK40060850A (en) Method for the generation of a bivalent, bispecific antibody expressing cell by targeted integration of multiple expression cassettes in a defined organization
HK40041212A (en) Targeted integration of nucleic acids
HK40063614A (zh) 通过以限定的组织形式靶向整合多个表达盒来产生多价多特异性抗体表达细胞的方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251217

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251217